**The ongoing federal marijuana rescheduling process under the Controlled Substances Act drives trader sentiment for this market.** Partial movement of FDA-approved products and state-regulated medical marijuana to Schedule III took effect in late April 2026 following a December 2025 executive order directing expedited rulemaking. A new administrative hearing on broader rescheduling from Schedule I to Schedule III convened June 29 and concluded no later than July 15, 2026, at DEA headquarters, providing the procedural record for a final agency decision. Current odds reflect uncertainty over the timeline for any final rule, with traders weighing the pace of post-hearing review against historical administrative delays and potential further procedural steps. No resolution has occurred as of mid-August 2026.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update$791,987 Vol.
September 30
14%
December 31
27%
$791,987 Vol.
September 30
14%
December 31
27%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Binuksan ang Market: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...**The ongoing federal marijuana rescheduling process under the Controlled Substances Act drives trader sentiment for this market.** Partial movement of FDA-approved products and state-regulated medical marijuana to Schedule III took effect in late April 2026 following a December 2025 executive order directing expedited rulemaking. A new administrative hearing on broader rescheduling from Schedule I to Schedule III convened June 29 and concluded no later than July 15, 2026, at DEA headquarters, providing the procedural record for a final agency decision. Current odds reflect uncertainty over the timeline for any final rule, with traders weighing the pace of post-hearing review against historical administrative delays and potential further procedural steps. No resolution has occurred as of mid-August 2026.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update



Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong